SGO, 2025 Annual Meeting on Women’s Cancer. Azenosertib median duration of response updated to 6.3 months in the ongoing ...

with a 6-month PFS rate of 73.8% (95% CI 50.7-87.3), he said in a presentation at the Society of Gynecologic Oncology (SGO) annual meeting in Seattle. "Addition of metformin to letrozole and ...